Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
Vivos Therapeutics announced the issuance of a new US patent (No. 12,697,190) that broadens protection for its Vivos CARE oral medical devices, designed to treat obstructive sleep apnea (OSA). This continuation patent complements their earlier patent, enhancing protection against competitors. With FDA 510(k) clearances for treating severe OSA in ad…